Expanded Custom Recombinant Protein and Antibody Services
What’s New at Conigen: Expanded Custom Recombinant Protein and Antibody Services As part of our commitment to supporting discovery with high-quality, native-like proteins, Conigen has expanded its custom protein expression and antibody solutions. These services are built on our proprietary technology platforms and decades of applied experience in protein expression, antibody generation, and functional validation. […]
Conigen at AAI & PEGS 2025 | Data on GPCRs, Cytokine Receptors, and Checkpoint Proteins
What’s New at Conigen: Conformational Recombinant Proteins with New Data, New Insights — See Us at AAI 2025 and PEGS In addition to expanding our portfolio of recombinant proteins that mimic nature, Conigen scientists will be presenting new data at two leading scientific conferences this May, AAI 2025 (booth #539) in Honolulu and PEGS (booth #511) […]
What’s New at Conigen: Recombinant Proteins that Mimic Nature, Ready for Discovery
What’s New at Conigen: Bioactive Recombinant Proteins for Drug Discovery and Antibody Screening Conigen Bioscience is expanding its portfolio of functional conformational recombinant proteins — designed to mimic native protein structure and function for drug discovery, antibody screening, and translational research. These recombinant proteins are designed using either the CSP™ (Conigen Soluble Protein) or CMP™ (Conigen […]
Conigen Bioscience and North Star Scientific, Inc. Partner to Broaden Access toNext-Generation Dimeric-Specific Epitope Tool-Molecules, Empowering Drug Discovery
Conigen Bioscience and North Star Scientific, Inc. Partner to Broaden Access to Next-Generation Dimeric-Specific Epitope Tool-Molecules, Empowering Drug Discovery Worcester, MA — January 7, 2025 — Conigen Bioscience, Inc., based in Worcester, Massachusetts, has partnered with North Star Scientific, Inc. to expand access to its transformative protein tools across North America. Conigen pioneers innovations in […]